Related references
Note: Only part of the references are listed.Overexpression of Rab5a promotes hepatocellular carcinoma cell proliferation and invasion via FAK signaling pathway
Donghua Geng et al.
TUMOR BIOLOGY (2016)
MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma
Jing-Song Chen et al.
CANCER LETTERS (2016)
FAK Kinase Activity Is Required for the Progression of c-MET/β-Catenin-Driven Hepataocellular Carcinoma
Na Shang et al.
GENE EXPRESSION (2016)
Hepatic Stellate Cells Induce Hepatocellular Carcinoma Cell Resistance to Sorafenib Through the Laminin-332/α3 Integrin Axis Recovery of Focal Adhesion Kinase Ubiquitination
Amalia Azzariti et al.
HEPATOLOGY (2016)
CT-707, a Novel FAK Inhibitor, Synergizes with Cabozantinib to Suppress Hepatocellular Carcinoma by Blocking Cabozantinib-Induced FAK Activation
Dan-Dan Wang et al.
MOLECULAR CANCER THERAPEUTICS (2016)
ASPP2 suppresses stem cell-like characteristics and chemoresistance by inhibiting the Src/FAK/Snail axis in hepatocellular carcinoma
Lu Xu et al.
TUMOR BIOLOGY (2016)
Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling
P-F Zhang et al.
CELL DEATH & DISEASE (2016)
Matrix stiffness-mediated effects on stemness characteristics occurring in HCC cells
Yang You et al.
ONCOTARGET (2016)
First- and Second-Line Targeted Systemic Therapy in Hepatocellular Carcinoma-An Update on Patient Selection and Response Evaluation
Johann von Felden et al.
DIAGNOSTICS (2016)
Nuclear FAK Controls Chemokine Transcription, Tregs, and Evasion of Anti-tumor Immunity
Alan Serrels et al.
CELL (2015)
Sinulariolide Suppresses Human Hepatocellular Carcinoma Cell Migration and Invasion by Inhibiting Matrix Metalloproteinase-2/-9 through MAPKs and PI3K/Akt Signaling Pathways
Yu-Jen Wu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling
Xin Yin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
FAK signaling in human cancer as a target for therapeutics
Brian Y. Lee et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Corosolic Acid Inhibits Hepatocellular Carcinoma Cell Migration by Targeting the VEGFR2/Src/FAK Pathway
Chung-Yu Ku et al.
PLOS ONE (2015)
Focal Adhesion Kinase and Wnt Signaling Regulate Human Ductal Carcinoma In Situ Stem Cell Activity and Response to Radiotherapy
Kathryn E. Williams et al.
STEM CELLS (2015)
Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma
Mitsuro Kanda et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Thyroid hormone-mediated regulation of lipocalin 2 through the Met/FAK pathway in liver cancer
I-Hsiao Chung et al.
ONCOTARGET (2015)
3′3-Diindolylmethane inhibits migration, invasion and metastasis of hepatocellular carcinoma by suppressing FAK signaling
Wen-Xue Li et al.
ONCOTARGET (2015)
TIMP-1 mediates TGF-β-dependent crosstalk between hepatic stellate and cancer cells via FAK signaling
Sang-A Park et al.
SCIENTIFIC REPORTS (2015)
Emerging Roles of Focal Adhesion Kinase in Cancer
Yu-Ling Tai et al.
BIOMED RESEARCH INTERNATIONAL (2015)
The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma
Elisabetta Rovida et al.
GUT (2015)
FAK Is Required for c-Met/beta-Catenin-Driven Hepatocarcinogenesis
Na Shang et al.
HEPATOLOGY (2015)
Emerging Trends in Hepatocellular Carcinoma Incidence and Mortality
Basile Njei et al.
HEPATOLOGY (2015)
Understanding the Roles of FAK in Cancer: Inhibitors, Genetic Models, and New Insights
Hyunho Yoon et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2015)
The mutational landscape of hepatocellular carcinoma
Ju-Seog Lee
CLINICAL AND MOLECULAR HEPATOLOGY (2015)
FAK dimerization controls its kinase-dependent functions at focal adhesions
Karen Brami-Cherrier et al.
EMBO JOURNAL (2014)
Targeting FAK in human cancer: from finding to first clinical trials
Vita M. Golubovskaya
FRONTIERS IN BIOSCIENCE-LANDMARK (2014)
Genomic Portrait of Resectable Hepatocellular Carcinomas: Implications of RB1 and FGF19 Aberrations for Patient Stratification
Sung-Min Ahn et al.
HEPATOLOGY (2014)
Downregulation of Notch1 inhibits the invasion of human hepatocellular carcinoma HepG2 and MHCC97H cells through the regulation of PTEN and FAK
Yan-Jian Hu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2014)
Merlin Deficiency Predicts FAK Inhibitor Sensitivity: A Synthetic Lethal Relationship
Irina M. Shapiro et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
FAK and paxillin dynamics at focal adhesions in the protrusions of migrating cells
Ying-Li Hu et al.
SCIENTIFIC REPORTS (2014)
The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update
Ming Liu et al.
PROTEIN & CELL (2014)
Molecular Biology of Liver Cancer Stem Cells
Naoki Oishi et al.
LIVER CANCER (2014)
FAK in cancer: mechanistic findings and clinical applications
Florian J. Sulzmaier et al.
NATURE REVIEWS CANCER (2014)
FAK and Nanog Cross Talk with p53 in Cancer Stem Cells
Vita M. Golubovskaya
Anti-Cancer Agents in Medicinal Chemistry (2013)
Next generation sequencing reveals genetic landscape of hepatocellular carcinomas
Shuyu Li et al.
CANCER LETTERS (2013)
Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma
Zhengyan Kan et al.
GENOME RESEARCH (2013)
MicroRNAs: New Tools for Diagnosis, Prognosis, and Therapy in Hepatocellular Carcinoma?
Silvia Giordano et al.
HEPATOLOGY (2013)
Argonaute2 Promotes Tumor Metastasis by Way of Up-regulating Focal Adhesion Kinase Expression in Hepatocellular Carcinoma
Na Cheng et al.
HEPATOLOGY (2013)
NANOG promotes liver cancer cell invasion by inducing epithelial-mesenchymal transition through NODAL/SMAD3 signaling pathway
Chun Sun et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
Cancer stem cells in the development of liver cancer
Taro Yamashita et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Nuclear FAK: a new mode of gene regulation from cellular adhesions
Ssang-Taek Steve Lim
MOLECULES AND CELLS (2013)
Disrupting the Scaffold to Improve Focal Adhesion Kinase-Targeted Cancer Therapeutics
William G. Cance et al.
SCIENCE SIGNALING (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
FAK Inhibition Decreases Hepatoblastoma Survival Both In Vitro and In Vivo
Lauren A. Gillory et al.
TRANSLATIONAL ONCOLOGY (2013)
Mechanisms of resistance to sorafenib and the corresponding strategies in hepatocellular carcinoma
Bo Zhai et al.
WORLD JOURNAL OF HEPATOLOGY (2013)
FAK and p53 Protein Interactions
Vita M. Golubovskaya et al.
Anti-Cancer Agents in Medicinal Chemistry (2012)
Cancer Stem Cells: Distinct Entities or Dynamically Regulated Phenotypes?
Yunqing Li et al.
CANCER RESEARCH (2012)
A small molecule focal adhesion kinase (FAK) inhibitor, targeting Y397 site: 1-(2-hydroxyethyl)-3, 5, 7-triaza-1-azoniatricyclo [3.3.1.13,7]decane; bromide effectively inhibits FAK autophosphorylation activity and decreases cancer cell viability, clonogenicity and tumor growth in vivo
Vita M. Golubovskaya et al.
CARCINOGENESIS (2012)
Focal adhesion kinase is required for β-catenin-induced mobilization of epidermal stem cells
Rachel A. Ridgway et al.
CARCINOGENESIS (2012)
VEGF-Induced Vascular Permeability Is Mediated by FAK
Xiao Lei Chen et al.
DEVELOPMENTAL CELL (2012)
Self-Renewal of Tumor-Initiating Cells: What's New About Hepatocellular Carcinoma?
Anna Alisi et al.
GASTROENTEROLOGY (2012)
Nanog Increases Focal Adhesion Kinase (FAK) Promoter Activity and Expression and Directly Binds to FAK Protein to Be Phosphorylated
Baotran Ho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
FAK promotes recruitment of talin to nascent adhesions to control cell motility
Christine Lawson et al.
JOURNAL OF CELL BIOLOGY (2012)
Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma
Florie Borel et al.
JOURNAL OF HEPATOLOGY (2012)
PTEN regulation of ERK1/2 signaling in cancer
Mahandranauth A. Chetram et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2012)
Prognostic factors and outcomes of patients with hepatocellular carcinoma in non-cirrhotic liver
Marcus A. Woerns et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)
Treatment of Hepatocellular Carcinoma: A Systematic Review
Shibo Lin et al.
LIVER CANCER (2012)
Notch signaling: simplicity in design, versatility in function
Emma R. Andersson et al.
DEVELOPMENT (2011)
CURRENT CONCEPTS Hepatocellular Carcinoma
Hashem B. El-Serag
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Hepatocellular Carcinoma: Current Management and Future Development-Improved Outcomes with Surgical Resection
Yoji Kishi et al.
INTERNATIONAL JOURNAL OF HEPATOLOGY (2011)
PND-1186 FAK inhibitor selectively promotes tumor cell apoptosis in three-dimensional environments
Isabelle Tanjoni et al.
CANCER BIOLOGY & THERAPY (2010)
FAK is involved in invasion and metastasis of hepatocellular carcinoma
Jing-Song Chen et al.
CLINICAL & EXPERIMENTAL METASTASIS (2010)
Stretchy Proteins on Stretchy Substrates: The Important Elements of Integrin-Mediated Rigidity Sensing
Simon W. Moore et al.
DEVELOPMENTAL CELL (2010)
Therapeutic potential and limitations of new FAK inhibitors in the treatment of cancer
Alexander Schultze et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions
Michael D. Schaller
JOURNAL OF CELL SCIENCE (2010)
The FERM domain: organizing the structure and function of FAK
Margaret C. Frame et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Signal transduction by focal adhesion kinase in cancer
Jihe Zhao et al.
CANCER AND METASTASIS REVIEWS (2009)
Sunitinib and PF-562,271 (FAK/Pyk2 inhibitor) effectively block growth and recovery of human hepatocellular carcinoma in a rat xenograft model
Cedo M. Bagi et al.
CANCER BIOLOGY & THERAPY (2009)
Mammary Epithelial-Specific Ablation of the Focal Adhesion Kinase Suppresses Mammary Tumorigenesis by Affecting Mammary Cancer Stem/Progenitor Cells
Ming Luo et al.
CANCER RESEARCH (2009)
Focal adhesion kinase: switching between GAPs and GEFs in the regulation of cell motility
Alok Tomar et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Liver Stem Cells and Hepatocellular Carcinoma
Lopa Mishra et al.
HEPATOLOGY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Environmental sensing through focal adhesions
Benjamin Geiger et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271
Walter Gregory Roberts et al.
CANCER RESEARCH (2008)
FERM control of FAK function - Implications for cancer therapy
Ssang-Taek Lim et al.
CELL CYCLE (2008)
Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation
Ssang-Taek Lim et al.
MOLECULAR CELL (2008)
Focal Adhesion Kinase Versus p53: Apoptosis or Survival?
William G. Cance et al.
SCIENCE SIGNALING (2008)
Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis
Asmaa Ibrahim Gomaa et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Fak/Src signaling in human intestinal epithelial cell survival and anoikis:: Differentiation State-specific uncouplin with the P13-K/Akt-1 ang MEK/Erk pathways
Vtronique Bouchard et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Focal adhesion kinase controls actin assembly via a FERM-mediated interaction with the Arp2/3 complex
Bryan Serrels et al.
NATURE CELL BIOLOGY (2007)
A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth
Qing Shi et al.
MOLECULAR CARCINOGENESIS (2007)
Combinatorial activation of FAK and AKT by transfonning growth factor-β1 confers an anoikis-resistant phenotype to myofibroblasts
Jeffrey C. Horowitz et al.
CELLULAR SIGNALLING (2007)
Origin of hepatocellular carcinoma: Role of stem cells
Xiong-Zhi Wu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
Crystal structure of the FERM domain of focal adhesion kinase
DFJ Ceccarelli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition
E Avizienyte et al.
CURRENT OPINION IN CELL BIOLOGY (2005)
The role of focal-adhesion kinase in cancer. A ew therapeutic opportunity
GW McLean et al.
NATURE REVIEWS CANCER (2005)
Direct interaction of the N-terminal domain of focal adhesion kinase with the N-terminal transactivation domain of p53
VM Golubovskaya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Resection and liver transplantation for hepatocellular carcinoma
JM Llovet et al.
SEMINARS IN LIVER DISEASE (2005)
P27Kip and cyclin D1 are necessary for focal adhesion kinase regulation of cell cycle progression in glioblastoma cells propagated in vitro and in vivo in the scid mouse brain
Q Ding et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Identification of Src-specific phosphorylation site on focal adhesion kinase: Dissection of the role of Src SH2 and catalytic functions and their consequences for tumor cell behavior
VG Brunton et al.
CANCER RESEARCH (2005)
Focal adhesion kinase regulates metastatic adhesion of carcinoma cells within liver sinusoids
A von Sengbusch et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
P53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression
TX Lin et al.
NATURE CELL BIOLOGY (2005)
Role of expression of focal adhesion kinase in progression of hepatocellular carcinoma
S Itoh et al.
CLINICAL CANCER RESEARCH (2004)
Focal adhesion kinase is overexpressed in hepatocellular carcinoma and can be served as an independent prognostic factor
T Fujii et al.
JOURNAL OF HEPATOLOGY (2004)
Analysis of DNA copy number aberrations in hepatitis C virus-associated hepatocellular carcinomas by conventional CGH and array CGH
K Hashimoto et al.
MODERN PATHOLOGY (2004)
Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor kappa B and p53 binding sites
V Golubovskaya et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2004)
PTK2 and EIF3S3 genes may be amplification targets at 8q23-q24 and are associated with large hepatocellular carcinomas
H Okamoto et al.
HEPATOLOGY (2003)
Transcriptional activation of cyclin D1 promoter by FAK contributes to cell cycle progression
J Zhao et al.
MOLECULAR BIOLOGY OF THE CELL (2001)
Analysis of differentially expressed genes in human hepatocellular carcinoma using suppression subtractive hybridization
Y Miyasaka et al.
BRITISH JOURNAL OF CANCER (2001)
A role for FAK in the concanavalin A-dependent secretion of matrix metalloproteinase-2 and-9
TT Sein et al.
ONCOGENE (2000)
Share Paper
